Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Starboard Takes $1B Stake In Pfizer
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.
Activist investor takes $1B stake in Pfizer, aims to turn around company
Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO Frank D’Amelio to assist in its plans.
Pfizer, GSK
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court.
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer as the pharmaceutical giant grapples with a downturn in demand for COVID-19 vaccines and treatments.
U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report
Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine. Read more here.
Pfizer, Arcadium Lithium, Richemont
Why Pfizer Stock Popped on Monday
How Pfizer got itself in a pickle. As the Journal explains, Pfizer bet big on vaccines to protect people from COVID, but as the pandemic waned, so did interest in (and sales of) i
Stocks to Watch Monday: Pfizer, Arcadium Lithium, Richemont
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported](
These Stocks Are Moving the Most Today: Pfizer, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, Duckhorn, and More
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Apple and Amazon shares are downgraded, and Rio Tinto approaches Arcadium Lithium about a potential acquisition.
7h
on MSN
Pfizer CEO’s Job Is at Risk. A Shot of Discipline Could Help.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
10h
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
FiercePharma
1h
Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support
Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...
21h
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
9h
Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
16h
Pfizer goes from hunter to hunted as Starboard circles
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
8h
Watch These Pfizer Price Levels as Stock Gains After Report of Starboard Taking Stake
Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor ...
11h
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Stocks
COVID
AI
RSV vaccine
Starboard
Feedback